Published: Sat, January 13, 2018
Business | By Tara Barton

Earnings Analysis Of Abbott Laboratories (ABT)

(NASDAQ:AMGN) for 1,155 shares. With 27,900 avg volume, 1 days are for Can-fite Biopharma Limited Adr (NYSEAMERICAN:CANF)'s short sellers to cover CANF's short positions. Heritage Trust Co now owns 2,175 shares of the healthcare product maker's stock worth $106,000 after acquiring an additional 200 shares in the last quarter. Stockholders of record on Friday, January 12th will be given a dividend of $0.28 per share. It has underperformed by 16.70% the S&P500.

Petersen Flynn & Dinsmore Inc increased its stake in Abbott Labs (ABT) by 5.2% based on its latest 2017Q3 regulatory filing with the SEC. Winfield Associates Inc. increased its position in Abbott Laboratories by 3.9% during the 2nd quarter. They are projecting Next Quarter growth of 16.7%.

Symphony Asset Management Llc decreased its stake in Abbott Labs (ABT) by 11.73% based on its latest 2017Q3 regulatory filing with the SEC.

Given what the insider ownership patterns are saying, it makes sense to consider the technicals to see if these pieces of information reach the same conclusion about the outlook for ABT. For the next 5 years, Abbott Laboratories is expecting Growth of 11.93% per annum, whereas in the past 5 years the growth was -5.71% per annum. It has underperformed by 0.80% the S&P500. It operates through four divisions: Mobile Systems, Automotive & Industrial, Connectivity, and Power Conversion. It has a 47.28 P/E ratio. The firm offers power management products, including PMICs, PMIC and audio, sub PMICs, and chargers; wireless connectivity solutions, such as Bluetooth low energy solutions, home automation solutions, and wireless and voice IC solutions for DECT and 2.4 GHz radio frequency bands; and audio chips comprising audio codecs, PMIC and audio, audio amplifiers, wireless audio, and USB audio solutions. It also upped Legg Mason Inc (NYSE:LM) stake by 12,300 shares and now owns 23,800 shares. The firm earned "Buy" rating on Monday, July 17 by Drexel Hamilton. Therefore 60% are positive. The firm earned "Equal-Weight" rating on Monday, January 4 by Morgan Stanley. As per Wednesday, October 11, the company rating was maintained by SunTrust. On Thursday, July 14 the stock rating was maintained by Jefferies with "Buy".

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24 before the open. During the same quarter in the previous year, the firm earned $0.59 earnings per share. analysts forecast that Abbott Laboratories will post 2.5 EPS for the current fiscal year. ABT's profit will be $1.27 billion for 20.08 P/E if the $0.73 EPS becomes a reality. The healthcare product maker reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.65 by $0.01.

The Cisco Systems, Inc. (CSCO) Receives Outperform Rating from William Blair
The company has a net profit margin of 20.30% and is more profitable than the average Networking & Communication Devices player. The company was maintained on Thursday, August 13 by Goldman Sachs. ( NASDAQ : CSCO ) on Tuesday, October 6 with "Buy" rating.

Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in a research note released on Tuesday, January 2nd. Therefore 72% are positive. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.29 Billion and the High Revenue Estimate is 7.49 Billion. The stock of Abbott Laboratories (NYSE:ABT) has "Buy" rating given on Monday, October 2 by RBC Capital Markets. Credit Suisse has "Outperform" rating and $55 target. Chicago Equity Prns Lc reported 0.01% in Abbott Laboratories (NYSE:ABT). On Thursday, August 31 the stock rating was maintained by BMO Capital Markets with "Hold".

Abbott Laboratories (ABT) augmented 0.17% to strike $58.92 in the Tuesday trading session. Imperial Capital maintained the stock with "In-Line" rating in Friday, November 13 report. Cowen & Co maintained the stock with "Buy" rating in Tuesday, August 15 report. Jefferies maintained the stock with "Buy" rating in Tuesday, September 13 report. Abbott Laboratories's dividend payout ratio (DPR) is presently 87.60%. As per Tuesday, January 2, the company rating was upgraded by JP Morgan. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data. Piper Jaffray maintained CyberArk Software Ltd. (NASDAQ:CYBR) on Tuesday, August 8 with "Buy" rating. Tealwood Asset Mgmt Incorporated stated it has 34,892 shares. Middleby Corp (NASDAQ:MIDD) was raised too.

Since August 1, 2017, it had 0 insider buys, and 6 insider sales for $22.86 million activity. Salvadori Daniel Gesua Sive sold 28,319 shares worth $1.56M. Shares for $2.74M were sold by Contreras Jaime on Friday, September 22.

Short interest is another tool that analysts use to gauge investor sentiment. Its down 0.01, from 0.88 in 2017Q2. It fall, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. 108 funds opened positions while 453 raised stakes. 9,595 are owned by Northstar Gru. Nationwide Fund Advisors reported 0.33% stake. Raymond James And reported 0.25% of its portfolio in Abbott Laboratories (NYSE:ABT). South State holds 0.39% of its portfolio in Abbott Laboratories (NYSE:ABT) for 65,717 shares. Liberty Capital Management owns 18,454 shares or 0.57% of their United States portfolio. Nbt Financial Bank N A stated it has 119,004 shares. 200 were reported by Capital Guardian Trust. Oarsman holds 0.26% or 11,678 shares. Finally, JFS Wealth Advisors LLC increased its position in Abbott Laboratories by 349.0% during the 2nd quarter. Deutsche Bank maintained the shares of ABT in report on Friday, July 21 with "Buy" rating. Daiwa Sb Invests Ltd accumulated 920 shares or 0.03% of the stock. Beaumont Financial Partners Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $102.26B market cap company.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: